These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 659893)

  • 21. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 22. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
    Herberman RB
    J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
    [No Abstract]   [Full Text] [Related]  

  • 23. Accessory cells in the in vitro generation of type C viruses specific T killer lymphocytes. I. Role of macrophages in primary anti-FMR reaction.
    Gomard E; Wybier-Franqui J; Levy JP
    J Immunol; 1981 Mar; 126(3):891-6. PubMed ID: 6257785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
    J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
    Robinson MK; Wheelock EF
    J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990
    [No Abstract]   [Full Text] [Related]  

  • 26. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic analysis of tumor-associated surface antigens on a Moloney leukemia virus-induced lymphoma, MBL-2.
    Ng AK; McIntire R; Holden HT; Herberman RB
    J Immunol; 1978 Sep; 121(3):856-62. PubMed ID: 690439
    [No Abstract]   [Full Text] [Related]  

  • 28. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction.
    Langlois AJ; Matthews T; Roloson GJ; Thiel HJ; Collins JJ; Bolognesi DP
    J Immunol; 1981 Jun; 126(6):2337-41. PubMed ID: 7229378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostimulatory factors specifically associated with a spontaneously regressing tumor subline of the murine leukemia L1210.
    Koo PH
    J Immunol; 1981 Jul; 127(1):373-9. PubMed ID: 7016996
    [No Abstract]   [Full Text] [Related]  

  • 32. Distinct signals for antibody-dependent and nonspecific killing of tumor targets mediated by macrophages.
    Ralph P; Williams N; Nakoinz I; Jackson H; Watson JD
    J Immunol; 1982 Jul; 129(1):427-32. PubMed ID: 7045225
    [No Abstract]   [Full Text] [Related]  

  • 33. Function and role of peritoneal macrophages in experimental leukaemia.
    Thi Phi Phi P; Nedelkova M; Serafimov-Dimitrov V
    Haematologia (Budap); 1981; 14(1):29-38. PubMed ID: 7250816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the susceptibility of C57BL-6 mice to Rauscher virus. 3. Kinetics of humoral antibody response to cell-surface antigens in neonatally inoculated mice.
    Ishimoto A; Ito Y
    J Natl Cancer Inst; 1973 Aug; 51(2):553-64. PubMed ID: 4765372
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
    Stutman O; Paige CJ; Figarella EF
    J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 37. Accessory cells in the in vitro generation of type C virus-specific T killer lymphocytes. II. Demonstration of a T helper cell in the spleen of in vivo primed mice.
    Gomard E; Wybier-Franqui J; Simmler MC; McKenzie IF; Levy JP
    J Immunol; 1981 Dec; 127(6):2291-5. PubMed ID: 6170695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of the strength of cell-cell adhesion: the capture of tumor cells by activated murine macrophages proceeds through two distinct stages.
    Somers SD; Whisnant CC; Adams DO
    J Immunol; 1986 Feb; 136(4):1490-6. PubMed ID: 3080524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 40. Humoral regulation of cell-mediated immunity to syngeneic tumor.
    Ting CC
    Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.